GABA Supplements Are Not Approved for Use in Children
GABA (gamma-aminobutyric acid) supplements are not approved for use in children, and there is insufficient evidence supporting their safety and efficacy in pediatric populations. 1, 2
Understanding GABA
GABA is a non-proteinogenic amino acid that functions as the main inhibitory neurotransmitter in the mammalian brain 3. While GABA plays important roles in:
- Stress reduction and relaxation effects 4
- Sleep enhancement 3
- Neurotransmission in the central nervous system 5
Regulatory Status for Children
The regulatory landscape for GABA supplements in children is clear:
- GABA supplements lack FDA approval for pediatric use 6, 7
- Pharmacotherapy in children and adolescents should only include approved medications with established safety profiles 1
- The use of unapproved supplements in children requires extreme caution due to lack of well-controlled studies and long-term safety data 1, 6
Evidence Gaps for Pediatric Use
Several critical limitations exist regarding GABA supplements for children:
- There is a lack of well-controlled studies on GABA supplements specifically in pediatric populations 3, 8
- No long-term safety data exists for GABA supplement use in children 8
- The risk versus long-term benefit ratio remains uncertain for unapproved supplements like GABA 1
Safety Concerns
The United States Pharmacopeia (USP) safety review of GABA identified several concerns:
- GABA can affect neurotransmitters and the endocrine system, including increases in growth hormone and prolactin levels 8
- GABA has been associated with transient and moderate drops in blood pressure in some studies 8
- Special caution is advised for pregnant and lactating women due to potential effects on neurotransmitters and the endocrine system 8
- Potential drug interactions exist, particularly with anti-hypertensive medications 8
Current Pediatric Medication Guidelines
For context, medications approved for pediatric use undergo rigorous testing:
- Medications for children require specific FDA approval with established safety and efficacy data 6, 7
- The FDA has established specific regulations governing drug testing in children to ensure safety 9
- Pharmacotherapy should only be considered for children when approved medications have demonstrated efficacy and safety in pediatric clinical trials 1
Clinical Implications
Healthcare providers should consider the following when addressing GABA supplement inquiries:
- Recommend only FDA-approved therapies with established pediatric safety profiles 6, 2
- Recognize that even for approved medications, pediatric pharmacotherapy requires close monitoring by qualified healthcare providers 1
- Be aware that most dietary supplements, including GABA, lack the rigorous testing required for pediatric medications 9, 8
- Consider that alternative pathways for addressing the symptoms for which GABA might be considered should utilize approved therapies 2
Conclusion
Given the lack of FDA approval, insufficient safety data, and absence of well-controlled studies in children, GABA supplements should not be used in pediatric populations. Healthcare providers should recommend only approved therapies with established safety profiles for children 1, 6, 8.